CompletedNot Applicable

High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Very Premature Infants: a Prospective Observational Study

Czechia65 participantsStarted 2021-02-01

Plain-language summary

A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.

Who can participate

Age range0 Minutes – 2 Minutes

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Preterm infants born between 28+0 and 31+6 gestational weeks were enrolled in the study after obtaining parental informed consent. Exclusion Criteria: * Infants with congenital malformations, previable rupture of membranes, and acute intrauterine hypoxia.

What they're measuring

HFNC slabilization

Timeframe: 10 minutes after delivery

Trial details

NCT IDNCT06458582

SponsorCharles University, Czech Republic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Premature; Infant trials